These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8513306)

  • 1. Coronary hemodynamics and the renin angiotensin system.
    Magrini F; Reggiani P; Paliotti R; Bonagura F; Ciulla M; Vandoni P
    Clin Exp Hypertens; 1993; 15 Suppl 1():139-55. PubMed ID: 8513306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
    Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary blood flow in renovascular hypertension.
    Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
    Am J Med; 1993 Apr; 94(4A):45S-48S. PubMed ID: 8488857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve.
    Magrini F; Reggiani P; Roberts N; Meazza R; Ciulla M; Zanchetti A
    Am J Med; 1988 Mar; 84(3A):55-60. PubMed ID: 3064599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting-enzyme inhibition and coronary blood flow.
    Magrini F; Shimizu M; Roberts N; Fouad FM; Tarazi RC; Zanchetti A
    Circulation; 1987 Jan; 75(1 Pt 2):I168-74. PubMed ID: 3024863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.
    Castoldi G; di Gioia CR; Travaglini C; Busca G; Redaelli S; Bombardi C; Stella A
    Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):205-9. PubMed ID: 17250640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
    Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
    Patel TV; Williams GH; Fisher ND
    J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
    Melaragno MG; Fink GD
    J Pharmacol Exp Ther; 1996 Jul; 278(1):297-303. PubMed ID: 8764363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
    Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
    Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary haemodynamic effects of angiotensin II in mild essential hypertension in man.
    Magrini F; Reggiani P; Ciulla M; Meazza R; Fratianni G
    Clin Sci (Lond); 1992 Feb; 82(2):133-7. PubMed ID: 1311650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S; Di Pasquale P; Parrinello G; Tuttolomondo A; Follone G; Cardinale A; Ortoleva A; Giambanco F; Abruzzese G; Colomba D; Bologna P; Fernández P; Giubilato A; Valdes L; Albano V; Licata G
    Drugs Exp Clin Res; 2000; 26(4):125-31. PubMed ID: 11109512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of angiotensin-II on lipolysis in humans.
    Townsend RR
    Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
    Schmitt SL; Taylor K; Schmidt R; Van Orden D; Williamson HE
    J Pharmacol Exp Ther; 1981 Nov; 219(2):407-14. PubMed ID: 7026766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.